{"database": "lobbying", "table": "lobbying_activities", "rows": [[2032770, "c5b8d8ac-1644-4fe0-b333-1abbda2589ab", "Q3", "GREATER NEW YORK HOSPITAL ASSOCIATION", 16830, "GREATER NEW YORK HOSPITAL ASSOCIATION", 2017, "third_quarter", "PHA", "Preserving access to group purchasing organizations (GPOs) and protecting the GPO safe harbor; educating policymakers on hospital drug shortages and significant drug price increases. \n\nSupport drug pricing legislation that would promote competition by fast tracking generic drug applications (H.R. 749/S.297).\n\nOppose legislation that would harm the 340B drug discount program for safety net hospitals.\n\nSupport reforms aimed at creating more competition in the generic drug market, including ending pay for delay (S.124) and prohibiting REMS abuses (S.944/H.R.2214)", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),White House Office", null, 600000, 0, 0, "2017-10-19T11:01:10.100000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2032770"], "units": {}, "query_ms": 0.7732849917374551, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}